LINH TRUONG: Open Payments
NPI 1346966132 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 20 payments from 10 companies in 2025. Trend: 2023 $579 · 2024 $1,098 · 2025 $407
Food & beverage: $337Education: $70
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $149 |
| PFIZER INC. | 4 | $78 |
| Organon LLC | 2 | $47 |
| Axsome Therapeutics, Inc. | 1 | $25 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Ascensia Diabetes Care Us Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $14 |
Products named: Veozah, NEXPLANON, PREVNAR 20, NURTEC ODT, Auvelity, JARDIANCE, Kerendia, Rybelsus.
Industry payments across TX — which companies pay providers there.
